HUP9904344A2 - Egyfázisú fogamzásgátló eljárás és progesztin és ösztrogén kombinációját tartalmazó kit - Google Patents
Egyfázisú fogamzásgátló eljárás és progesztin és ösztrogén kombinációját tartalmazó kitInfo
- Publication number
- HUP9904344A2 HUP9904344A2 HU9904344A HUP9904344A HUP9904344A2 HU P9904344 A2 HUP9904344 A2 HU P9904344A2 HU 9904344 A HU9904344 A HU 9904344A HU P9904344 A HUP9904344 A HU P9904344A HU P9904344 A2 HUP9904344 A2 HU P9904344A2
- Authority
- HU
- Hungary
- Prior art keywords
- progestin
- estrogen
- combination
- dosage units
- dose
- Prior art date
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title abstract 9
- 239000000262 estrogen Substances 0.000 title abstract 9
- 229940011871 estrogen Drugs 0.000 title abstract 9
- 239000000583 progesterone congener Substances 0.000 title abstract 9
- 239000003433 contraceptive agent Substances 0.000 title abstract 5
- 230000002254 contraceptive effect Effects 0.000 title abstract 5
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 abstract 2
- 229960003309 dienogest Drugs 0.000 abstract 2
- 230000001076 estrogenic effect Effects 0.000 abstract 2
- 229960002568 ethinylestradiol Drugs 0.000 abstract 2
- 230000027758 ovulation cycle Effects 0.000 abstract 2
- 239000000902 placebo Substances 0.000 abstract 2
- 229940068196 placebo Drugs 0.000 abstract 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 abstract 1
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 abstract 1
- 229960004845 drospirenone Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000000476 thermogenic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A találmány tárgya főgamzásgátló eljárás, amely abban áll, hőgyszülőképes kőrú nőnek prőgesztin és ösztrőgén kőmbinációját adagőlják,ahől a prőgesztin napi dózisa 40-500 mg trimegesztőn vagy 250 mg -4 mgdienőgeszt, vagy 250 mg-4 mg drőspirenőn, az ösztőrgén napi dózisa 10-20 mg etinil-ösztradiől ösztrőgén aktivitásának megfelelő, akőmbinációt a menstrűációs ciklűs első napjával kezdődően 23-25 napőnát adagőlják, és a 23-25 adagőlási nap sőrán a prőgesztin és ösztrőgénkőmbináció azőnős dózisát adagőlják. A 28 napős menstrűációs ciklűstővábbi napjain nem főgamzásgátló placebót, példáűl vaspótlástadagőlnak vagy a gyógyszer adagőlást szüneteltetik. A találmány tárgyatővábbá őrális adagőláshőz kialakítőtt főgamzásgátló kit, amely 23-25elkülönült prőgesztin és ösztrőgén kőmbinációs dózisegységettartalmaz, vagy 28 egymástól elkülönült dózisegységet tartalmaz,amelyek közül 23-25 dózisegység mindegyike prőgesztin és ösztrőgénkőmbinációját tartalmazza, ahől a prőgesztin 40-500 mg-4 mgtrimegesztőn vagy 250 mg-4 mg dienőgeszt, vagy 250 mg-4 mgdrőspirenőn, és az ösztrőgén- 10-20 mg etinil-ösztradiől ösztrőgénaktivitásának megfelelő dózisú ösztrőgén, és a dózisegységekmindegyike azőnős prőgesztin- és ösztrőgéndózist tartalmaz, tővábbá 3-5 dózisegység mindegyike nem főgamzásgátló placebót tartalmaz, és a23-25 dózisegység mindegyike azőnős prőgesztin- és ösztrőgéndózisttartalmaz. ŕ
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68679096A | 1996-07-26 | 1996-07-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9904344A2 true HUP9904344A2 (hu) | 2000-05-28 |
| HUP9904344A3 HUP9904344A3 (en) | 2001-03-28 |
Family
ID=24757773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9904344A HUP9904344A3 (en) | 1996-07-26 | 1997-07-23 | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0956024B1 (hu) |
| JP (1) | JP2000515890A (hu) |
| KR (1) | KR100518102B1 (hu) |
| CN (1) | CN1186024C (hu) |
| AT (1) | ATE271386T1 (hu) |
| AU (1) | AU726091B2 (hu) |
| BR (1) | BR9710566A (hu) |
| CA (1) | CA2261689A1 (hu) |
| DE (1) | DE69729956T2 (hu) |
| ES (1) | ES2223081T3 (hu) |
| HK (1) | HK1022843A1 (hu) |
| HU (1) | HUP9904344A3 (hu) |
| IL (1) | IL127797A (hu) |
| NZ (1) | NZ333750A (hu) |
| PT (1) | PT956024E (hu) |
| WO (1) | WO1998004269A1 (hu) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| EP1598069B1 (en) * | 1999-08-31 | 2009-04-22 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| RU2269342C2 (ru) * | 1999-08-31 | 2006-02-10 | Шеринг Акциенгезелльшафт | Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива |
| US6787531B1 (en) | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
| EP2305267A3 (en) * | 1999-08-31 | 2011-08-17 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| FR2801218B1 (fr) * | 1999-11-23 | 2001-12-28 | Hoechst Marion Roussel Inc | Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant |
| PT1611892E (pt) * | 2000-01-18 | 2009-11-20 | Bayer Schering Pharma Ag | Composições farmacêuticas compreendendo drospirenona |
| DE10045380A1 (de) | 2000-09-14 | 2002-04-04 | Schering Ag | Verfahren zur Kontrazeption und dessen Darreichungsform |
| WO2002047693A2 (en) * | 2000-12-14 | 2002-06-20 | Ortho-Mcneil Pharmaceutical, Inc. | Steroid hormone products comprising a stabilizing agent in non-crystalline form |
| EP1216713A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions of estrogen-cyclodextrin complexes |
| PT1635843E (pt) * | 2003-06-25 | 2009-04-07 | Bayer Schering Pharma Ag | Terapia de substituição hormonal e de depressão compreendendo dienogest |
| DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
| MY151322A (en) * | 2004-04-30 | 2014-05-15 | Bayer Ip Gmbh | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| AU2011226911B2 (en) * | 2004-04-30 | 2014-06-19 | Bayer Intellectual Property Gmbh | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| EP1773344A1 (en) | 2004-07-07 | 2007-04-18 | Wyeth a Corporation of the State of Delaware | Cyclic progestin regimens and kits |
| EP1690529A1 (de) * | 2005-02-15 | 2006-08-16 | Schering AG | Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält |
| DK1848406T3 (da) * | 2005-02-15 | 2008-09-15 | Jenapharm Gmbh | Fast, penoral lægemiddelform til kontraception, der indeholder dienogest og ethynylestradiol |
| EP1690543A1 (de) * | 2005-02-15 | 2006-08-16 | Schering AG | Pharmazeutisches Präparat zur Kontrazeption |
| DE102005034498A1 (de) * | 2005-07-20 | 2007-01-25 | Grünenthal GmbH | Orale Kontrazeption mit Trimegeston |
| US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
| EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
| DE102008040908A1 (de) | 2008-07-31 | 2010-02-11 | Deere & Company, Moline | Kühleranordnung für ein Fahrzeugkühlsystem |
| PL2324832T5 (pl) * | 2009-11-09 | 2017-10-31 | Biogena Naturprodukte Gmbh & Co Kg | Suplement diety przy przyjmowaniu hormonalnych środków antykoncepcyjnych |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK174724B1 (da) * | 1986-07-15 | 2003-10-06 | Wyeth Corp | Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet |
| IE71203B1 (en) * | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
| DE4344462C2 (de) * | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| DE4411585A1 (de) * | 1994-03-30 | 1995-10-05 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
| DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
-
1997
- 1997-07-23 BR BR9710566A patent/BR9710566A/pt not_active Application Discontinuation
- 1997-07-23 JP JP10508924A patent/JP2000515890A/ja not_active Ceased
- 1997-07-23 CA CA002261689A patent/CA2261689A1/en not_active Abandoned
- 1997-07-23 EP EP97936149A patent/EP0956024B1/en not_active Revoked
- 1997-07-23 HU HU9904344A patent/HUP9904344A3/hu unknown
- 1997-07-23 CN CNB971967636A patent/CN1186024C/zh not_active Expired - Fee Related
- 1997-07-23 WO PCT/US1997/012795 patent/WO1998004269A1/en active Search and Examination
- 1997-07-23 AU AU38887/97A patent/AU726091B2/en not_active Ceased
- 1997-07-23 NZ NZ333750A patent/NZ333750A/xx unknown
- 1997-07-23 DE DE69729956T patent/DE69729956T2/de not_active Expired - Fee Related
- 1997-07-23 PT PT97936149T patent/PT956024E/pt unknown
- 1997-07-23 ES ES97936149T patent/ES2223081T3/es not_active Expired - Lifetime
- 1997-07-23 KR KR10-1999-7000553A patent/KR100518102B1/ko not_active IP Right Cessation
- 1997-07-23 AT AT97936149T patent/ATE271386T1/de not_active IP Right Cessation
- 1997-07-23 IL IL12779797A patent/IL127797A/en not_active IP Right Cessation
-
2000
- 2000-03-31 HK HK00101976A patent/HK1022843A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL127797A (en) | 2004-08-31 |
| HUP9904344A3 (en) | 2001-03-28 |
| CN1226168A (zh) | 1999-08-18 |
| NZ333750A (en) | 2000-09-29 |
| EP0956024B1 (en) | 2004-07-21 |
| AU3888797A (en) | 1998-02-20 |
| KR100518102B1 (ko) | 2005-10-04 |
| AU726091B2 (en) | 2000-11-02 |
| HK1022843A1 (en) | 2000-08-25 |
| WO1998004269A1 (en) | 1998-02-05 |
| CA2261689A1 (en) | 1998-02-05 |
| KR20000029515A (ko) | 2000-05-25 |
| ES2223081T3 (es) | 2005-02-16 |
| DE69729956D1 (de) | 2004-08-26 |
| PT956024E (pt) | 2004-10-29 |
| EP0956024A1 (en) | 1999-11-17 |
| ATE271386T1 (de) | 2004-08-15 |
| JP2000515890A (ja) | 2000-11-28 |
| CN1186024C (zh) | 2005-01-26 |
| IL127797A0 (en) | 1999-10-28 |
| DE69729956T2 (de) | 2004-12-16 |
| BR9710566A (pt) | 1999-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9904344A2 (hu) | Egyfázisú fogamzásgátló eljárás és progesztin és ösztrogén kombinációját tartalmazó kit | |
| FI103951B (fi) | Ehkäisyjärjestelmä | |
| GB2192542B (en) | Combination dosage form for pre-menopausal women | |
| JPH04290828A (ja) | 低エストロゲン経口避妊薬 | |
| WO1998004246A3 (en) | Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| NZ333862A (en) | Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen | |
| HUP9900612A2 (hu) | Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra | |
| DE69724796D1 (de) | Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten | |
| AU759925B2 (en) | Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin | |
| WO1999051214A2 (en) | Progestogen-only contraceptive kit |